Evidence map›Paper›PMID 35465917›Full record

ArticleMethods in enzymology2022

Advances in rapid scan EPR spectroscopy.

Gareth R Eaton, Sandra S Eaton

Abstract read
In one paragraph

Article in Methods in enzymology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Celebration of 80 years of EPR.Applied magnetic resonance · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Rapid scan EPR: Automated digital resonator control for low-latency data acquisition.Journal of magnetic resonance (San Diego, Calif. : 1997) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gareth R EatonDepartment of Chemistry and Biochemistry, University of Denver, Denver, CO, United States. Electronic address: gareth.eaton@du.edu.
Sandra S EatonDepartment of Chemistry and Biochemistry, University of Denver, Denver, CO, United States.

Funding

Rapid Scan Biomedical EPR Spectroscopy and ImagingR01EB000557 · NIBIB · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI EATON, GARETH R · 2002 to 2011
$4.0M
Preclinical Electron Paramagnetic Resonance Tumor ImagerR01CA177744 · NCI · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI EATON, GARETH R · 2014 to 2019
$2.7M
Preclinical Electron Paramagnetic Resonance Tumor ImagerR01CA262159 · NCI · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI EATON, GARETH R · 2021 to 2025
$2.6M
Rapid Scan Biomedical EPR Spectroscopy and ImagingR56EB000557 · NIBIB · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI EATON, GARETH R · 2007 to 2007
$494k
NCI NIH HHS R01 CA177744NCI NIH HHS R01 CA262159NIBIB NIH HHS R01 EB000557NIBIB NIH HHS R56 EB000557
6 · The paper itself

Abstract

Progress has been made in hardware for low frequencies, demonstrations of rapid frequency scans, hybrid instrumentation, and improved deconvolution software. The recent availability of the commercial Bruker BioSpin rapid scan accessory for their X-band EMX and Elexsys systems makes this technique available to a wide range of users without the need to construct their own system. Developments at lower frequencies are underway in several labs with the goal of facilitating in vivo and preclinical rapid scan imaging. Development of new deconvolution algorithms will make data processing more robust. Frequency scans have substantial promise at higher frequencies. New examples of applications show the wide applicability and advantages of rapid scan.

Indexed as

AlgorithmsElectron Spin Resonance SpectroscopyElectron paramagnetic resonanceIn vivo EPRResolution of hyperfine splittingsSignal-to-noise

Identifiers

PMID35465917
PMCPMC10093151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.